Compare Gemini Space Station Inc (GEMI) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gemini Space Station Inc vs GeneDx Holdings Corp — how do they compare? Gemini Space Station Inc trades at $4.5 (market cap $590.44M), while GeneDx Holdings Corp trades at $61.39 (market cap $1.96B). The key difference: GeneDx Holdings Corp is far larger — about 3.3× Gemini Space Station Inc's market cap, and GeneDx Holdings Corp is trading nearer its 52-week high, Gemini Space Station Inc nearer its low. Which is the better fit depends on your goals.
| GEMI | WGS | |
|---|---|---|
Market Cap | $590.44M | $1.96B |
Sector | Technology | Technology |
52-Week High | $32.52 | $167.51 |
52-Week Low | $3.91 | $34.51 |
Enterprise Value | $580.43M | $1.96B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GEMI stock trades at $4.59, up 5.76% on the day, while showing a mixed technical picture with a bullish overall signal but bearish moving averages. Fundamentally, the company faces significant challenges with deep losses, negative profit margins, and consecutive earnings misses, despite recent strategic investments. Analyst sentiment is divided with a consensus price target of $5.88, representing a 28% potential upside from current levels.
The outlook balances speculative upside from strategic capital injections and expansion into commission-free trading against severe fundamental weaknesses and ongoing securities litigation. The primary investment opportunity lies in the potential execution of its financial super app strategy, while key risks include unsustainable cash burn, class action lawsuits, and failure to achieve profitability.
WGS trades at $62.73, up 0.48% on the day, amid a bearish technical signal and negative earnings momentum. The stock faces significant headwinds from a class action lawsuit alleging securities fraud tied to a 49% stock decline, while fundamentals show a net loss of $21.02 million in 2025 and deteriorating profitability into 2026. Analyst consensus remains bullish with a $75.40 price target, but recent news flow is overwhelmingly negative.
The outlook is clouded by legal risks and weak financial performance, though analyst optimism suggests potential recovery if the company can stabilize operations. Key risks include litigation outcomes, execution on profitability, and market sentiment shifts. The stock's trajectory hinges on resolving legal challenges and demonstrating sustainable earnings improvement.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Gemini Space Station Inc
Gemini Space Station Inc is the parent company of the Gemini crypto ecosystem, founded by Cameron and Tyler Winklevoss. It operates as a regulated digital asset exchange and custodian, providing a platform for individuals and institutions to trade, store, and stake cryptocurrencies while serving as a trusted bridge between legacy finance and the decentralized web.
Read more on GEMI →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
